# Xultophy 100/3.6

NDC: 0169-2911
Generic name: insulin degludec and liraglutide
Labeler / Manufacturer: Novo Nordisk
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20161121

FDA application: BLA208583

## Active ingredients

- INSULIN DEGLUDEC: 100 [iU]/mL
- LIRAGLUTIDE: 3.6 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0169-2911"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0169-2911
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=21335fe4-d395-4501-ac2a-2f20d7520da9